EUVIMEDEUVIMED entdecken
Crossref

Pattern of Agreement Among Medications Used During Pregnancy as Recorded in Self‐Report and Administrative Claims From California

Jonathan A Mayo iD, Chen Ma, Gary M Shaw iD

Birth Defects Research · 2026

DOI: 10.1002/bdr2.70080 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Birth Defects Research, 2026. Verfasst von Jonathan A Mayo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Neonatal and Developmental Medicine, Stanford University School of Medicine, Stanford, California, USA. Hauptthemen laut MEDLINE: Self Report. Die Arbeit nennt 20 Literaturangaben. Gefördert von: CDC HHS, Centers for Disease Control and Prevention.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Medication usage prior to conception and over the duration of pregnancy is common. Two frequent sources that record such medications are self‐report and administrative databases. Our goal was to examine the pattern of agreement among medications reported in each source.

Methods

We linked all interviewed subjects recruited for the Birth Defects Study To Evaluate Pregnancy exposureS (BD‐STEPS) in California to their Medi‐Cal insurance claims. BD‐STEPS is a population‐based case–control study including livebirths, stillbirths, and terminations with a major birth defect and livebirth controls without defects. Among 195 California BD‐STEPS participants that completed a structured interview and linked to their Medi‐Cal claims, we compared the agreement of self‐reported medication use with that documented in insurance claims using the simple kappa statistic and 95% confidence intervals.

Results

Among the 195 subjects, accounting for both sources there were a total 128 medications recorded. Agreement between self‐report and Medi‐Cal claims based on the kappa statistic varied considerably; for example, we found that acetaminophen [ k = 0.06 (−0.04, 0.15)], amoxicillin [ k = 0.05 (−0.12, 0.21)], ibuprofen [ k = 0.02 (−0.10, 0.14)], and ondansetron [ k = 0.11 (−0.07, 0.28)] all had poor agreement. Five medications showed perfect agreement [ k = 1.00 (1.00, 1.00)] including amlodipine, glyburide, methimazole, metoprolol, and mirtazapine. For some medications agreement varied by case and control status or time to recall, but estimates were often imprecise.

Conclusion

Medication reporting during pregnancy that comes from administrative claims and self‐report each have their distinct advantages and limitations. Understanding how and why certain medications will populate one but not the other is an important consideration. Data drawn from multiple sources have the ability to complement one another, perhaps more so than confirm.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Self ReportHumansFemalePregnancyCaliforniaCase-Control StudiesAdult

Autor:innen und Institutionen

  • Department of Pediatrics, Division of Neonatal and Developmental Medicine, Stanford University School of Medicine, Stanford, California, USA.

ORCID-Profile: Jonathan A Mayo, Gary M Shaw

Förderung

  • CDC HHS
  • Centers for Disease Control and Prevention

Zitieren

APA

Mayo, J. A., Ma, C., & Shaw, G. M. (2026). Pattern of Agreement Among Medications Used During Pregnancy as Recorded in Self‐Report and Administrative Claims From California. Birth Defects Research. https://doi.org/10.1002/bdr2.70080

Vancouver

Mayo JA, Ma C, Shaw GM. Pattern of Agreement Among Medications Used During Pregnancy as Recorded in Self‐Report and Administrative Claims From California. Birth Defects Research. 2026. doi:10.1002/bdr2.70080

BibTeX
@article{Mayo2026,
  author = {Mayo, Jonathan A and Ma, Chen and Shaw, Gary M},
  title = {Pattern of Agreement Among Medications Used During Pregnancy as Recorded in Self‐Report and Administrative Claims From California},
  journal = {Birth Defects Research},
  year = {2026},
  doi = {10.1002/bdr2.70080}
}
Kostenlos starten →